Breaking News Instant updates and real-time market news.

PDD

Pinduoduo

$96.99 /

+2.92 (+3.10%)

14:25
10/18/21
10/18
14:25
10/18/21
14:25

Pinduoduo call volume above normal and directionally bullish

Bullish option flow detected in Pinduoduo with 15,337 calls trading, 1.2x expected, and implied vol increasing almost 2 points to 60.34%. Nov-21 115 calls and Nov-21 104 calls are the most active options, with total volume in those strikes near 3,900 contracts. The Put/Call Ratio is 0.30. Earnings are expected on November 11th.

  • 18

    Nov

PDD Pinduoduo
$96.99 /

+2.92 (+3.10%)

08/25/21 BofA
Pinduoduo price target raised to $148 from $143 at BofA
08/25/21 Benchmark
Pinduoduo price target lowered to $156 from $176 at Benchmark
08/25/21 Citi
Pinduoduo price target lowered to $140 from $168 at Citi
08/06/21
Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Conference/Events
Shift Technologies management to meet virtually with Piper Sandler » 14:49
11/29/21
11/29
14:49
11/29/21
14:49
SFT

Shift Technologies

$4.62 /

-0.14 (-2.94%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFT Shift Technologies
$4.62 /

-0.14 (-2.94%)

SFT Shift Technologies
$4.62 /

-0.14 (-2.94%)

11/12/21 Piper Sandler
Piper says buy 'grossly undervalued' Shift Technologies after Q3 beat
10/05/21 JPMorgan
Shift Technologies initiated with Overweight, $12 target at JPMorgan
10/05/21 JPMorgan
Shift Technologies initiated with an Overweight at JPMorgan
09/10/21 Truist
Truist starts Shift Technologies at Buy as 'disruptive' auto e-commerce player
SFT Shift Technologies
$4.62 /

-0.14 (-2.94%)

SFT Shift Technologies
$4.62 /

-0.14 (-2.94%)

SFT Shift Technologies
$4.62 /

-0.14 (-2.94%)

Periodicals
Sonos likely planning smaller, cheaper Sub Mini subwoofer, Verge says » 14:49
11/29/21
11/29
14:49
11/29/21
14:49
SONO

Sonos

$32.75 /

+0.475 (+1.47%)

Sonos likely intends to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SONO Sonos
$32.75 /

+0.475 (+1.47%)

SONO Sonos
$32.75 /

+0.475 (+1.47%)

11/18/21 Morgan Stanley
Sonos price target raised to $53 from $51 at Morgan Stanley
09/14/21 Jefferies
Sonos price hikes support view FY22 consensus too low, says Jefferies
08/16/21
Fly Intel: Top five analyst upgrades
08/16/21 Jefferies
Sonos upgraded to Buy from Hold at Jefferies
SONO Sonos
$32.75 /

+0.475 (+1.47%)

SONO Sonos
$32.75 /

+0.475 (+1.47%)

SONO Sonos
$32.75 /

+0.475 (+1.47%)

SONO Sonos
$32.75 /

+0.475 (+1.47%)

Conference/Events
Impinj management to meet with Piper Sandler » 14:47
11/29/21
11/29
14:47
11/29/21
14:47
PI

Impinj

$76.98 /

+2.65 (+3.57%)

Meeting to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PI Impinj
$76.98 /

+2.65 (+3.57%)

11/17/21 Canaccord
Impinj price target raised to $95 from $75 at Canaccord
10/28/21 Needham
Impinj price target raised to $63 from $55 at Needham
10/28/21 Roth Capital
Impinj price target lowered to $68 from $74 at Roth Capital
10/26/21
Fly Intel: Top five analyst initiations
PI Impinj
$76.98 /

+2.65 (+3.57%)

PI Impinj
$76.98 /

+2.65 (+3.57%)

Conference/Events
Vizio management to meet with Piper Sandler » 14:47
11/29/21
11/29
14:47
11/29/21
14:47
VZIO

Vizio

$19.99 /

-0.21 (-1.04%)

Group luncheon meeting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VZIO Vizio
$19.99 /

-0.21 (-1.04%)

VZIO Vizio
$19.99 /

-0.21 (-1.04%)

11/17/21 Barrington
Vizio initiated with an Outperform at Barrington
11/10/21 Piper Sandler
Vizio price target lowered to $29 from $31 at Piper Sandler
10/11/21 Stephens
Vizio CTO exit not tied to any recent underperformance, says Stephens
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
VZIO Vizio
$19.99 /

-0.21 (-1.04%)

  • 25
    Mar
VZIO Vizio
$19.99 /

-0.21 (-1.04%)

VZIO Vizio
$19.99 /

-0.21 (-1.04%)

Hot Stocks
CorVel director Hamerslag sells 5,000 common shares » 14:46
11/29/21
11/29
14:46
11/29/21
14:46
CRVL

CorVel

$188.38 /

-2.25 (-1.18%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRVL CorVel
$188.38 /

-2.25 (-1.18%)

Periodicals
Judge halts Biden's health worker vaccine mandate in 10 states, The Hill says » 14:45
11/29/21
11/29
14:45
11/29/21
14:45
MRNA

Moderna

$368.23 /

+38.4 (+11.64%)

, PFE

Pfizer

$53.40 /

-0.43 (-0.80%)

, BNTX

BioNTech

$361.19 /

+9.74 (+2.77%)

, AZN

AstraZeneca

$55.70 /

-0.875 (-1.55%)

, JNJ

Johnson & Johnson

$160.20 /

+1.53 (+0.96%)

, NVAX

Novavax

$210.50 /

-7.32 (-3.36%)

, CVAC

CureVac

$46.15 /

+2 (+4.53%)

, VXRT

Vaxart

$7.75 /

+0.26 (+3.47%)

A Missouri-based federal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$368.23 /

+38.4 (+11.64%)

PFE Pfizer
$53.40 /

-0.43 (-0.80%)

BNTX BioNTech
$361.19 /

+9.74 (+2.77%)

AZN AstraZeneca
$55.70 /

-0.875 (-1.55%)

JNJ Johnson & Johnson
$160.20 /

+1.53 (+0.96%)

NVAX Novavax
$210.50 /

-7.32 (-3.36%)

CVAC CureVac
$46.15 /

+2 (+4.53%)

VXRT Vaxart
$7.75 /

+0.26 (+3.47%)

MRNA Moderna
$368.23 /

+38.4 (+11.64%)

11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
PFE Pfizer
$53.40 /

-0.43 (-0.80%)

09:51 Today Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
09:50 Today Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
07:28 Today JPMorgan
Pfizer price target raised to $53 from $42 at JPMorgan
11/26/21 Citi
Pfizer can deliver novel vaccine within 100 days of sequencing, says Citi
BNTX BioNTech
$361.19 /

+9.74 (+2.77%)

08:31 Today UBS
BioNTech to benefit if concerns about omicron variant increase, says UBS
11/10/21
Fly Intel: Top five analyst upgrades
11/10/21 H.C. Wainwright
H.C. Wainwright upgrades BioNTech to Buy ahead of likely booster approval
11/10/21 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
AZN AstraZeneca
$55.70 /

-0.875 (-1.55%)

13:42 Today Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
10/27/21 SVB Leerink
Seagen price target raised to $200 from $190 at SVB Leerink
10/19/21 UBS
AstraZeneca price target raised to 10,000 GBp from 9,200 GBp at UBS
JNJ Johnson & Johnson
$160.20 /

+1.53 (+0.96%)

11:24 Today Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
NVAX Novavax
$210.50 /

-7.32 (-3.36%)

09:06 Today B. Riley
Omicron reemphasizes importance of Novavax vaccine, says B. Riley
11/08/21 B. Riley
Novavax not a one-trick pony, says B. Riley
10/20/21 Cantor Fitzgerald
Novavax submissions will 'dissipate the current debate,' says Cantor Fitzgerald
09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
CVAC CureVac
$46.15 /

+2 (+4.53%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
CureVac initiated with a Hold at Deutsche Bank
07/01/21 Berenberg
CureVac COVID vaccine data may be enough for EU approval, says Berenberg
06/30/21
CureVac announces COVID vaccine candidate demonstrates 48% efficacy
VXRT Vaxart
$7.75 /

+0.26 (+3.47%)

11/02/21 Cantor Fitzgerald
Vaxart initiated with an Overweight at Cantor Fitzgerald
08/02/21 Piper Sandler
Piper 'pleased' to see Vaxart's IND clearance for S-only COVID vaccine candidate
06/30/21
Fly Intel: Top five analyst downgrades
06/30/21 B. Riley
B. Riley downgraded Vaxart to Neutral on 'riskier development path'
MRNA Moderna
$368.23 /

+38.4 (+11.64%)

PFE Pfizer
$53.40 /

-0.43 (-0.80%)

BNTX BioNTech
$361.19 /

+9.74 (+2.77%)

AZN AstraZeneca
$55.70 /

-0.875 (-1.55%)

JNJ Johnson & Johnson
$160.20 /

+1.53 (+0.96%)

NVAX Novavax
$210.50 /

-7.32 (-3.36%)

CVAC CureVac
$46.15 /

+2 (+4.53%)

VXRT Vaxart
$7.75 /

+0.26 (+3.47%)

  • 28
    Jan
MRNA Moderna
$368.23 /

+38.4 (+11.64%)

PFE Pfizer
$53.40 /

-0.43 (-0.80%)

BNTX BioNTech
$361.19 /

+9.74 (+2.77%)

AZN AstraZeneca
$55.70 /

-0.875 (-1.55%)

JNJ Johnson & Johnson
$160.20 /

+1.53 (+0.96%)

NVAX Novavax
$210.50 /

-7.32 (-3.36%)

CVAC CureVac
$46.15 /

+2 (+4.53%)

MRNA Moderna
$368.23 /

+38.4 (+11.64%)

PFE Pfizer
$53.40 /

-0.43 (-0.80%)

BNTX BioNTech
$361.19 /

+9.74 (+2.77%)

AZN AstraZeneca
$55.70 /

-0.875 (-1.55%)

JNJ Johnson & Johnson
$160.20 /

+1.53 (+0.96%)

NVAX Novavax
$210.50 /

-7.32 (-3.36%)

CVAC CureVac
$46.15 /

+2 (+4.53%)

VXRT Vaxart
$7.75 /

+0.26 (+3.47%)

MRNA Moderna
$368.23 /

+38.4 (+11.64%)

PFE Pfizer
$53.40 /

-0.43 (-0.80%)

BNTX BioNTech
$361.19 /

+9.74 (+2.77%)

AZN AstraZeneca
$55.70 /

-0.875 (-1.55%)

JNJ Johnson & Johnson
$160.20 /

+1.53 (+0.96%)

NVAX Novavax
$210.50 /

-7.32 (-3.36%)

CVAC CureVac
$46.15 /

+2 (+4.53%)

VXRT Vaxart
$7.75 /

+0.26 (+3.47%)

Conference/Events
Trupanion management to meet with Lake Street » 14:44
11/29/21
11/29
14:44
11/29/21
14:44
TRUP

Trupanion

$124.37 /

-2.06 (-1.63%)

Group dinner meeting with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRUP Trupanion
$124.37 /

-2.06 (-1.63%)

TRUP Trupanion
$124.37 /

-2.06 (-1.63%)

11/08/21 BofA
Trupanion downgraded to Neutral from Buy at BofA
10/18/21 BofA
BofA starts 'industry leader' Trupanion at Buy
10/18/21 BofA
Trupanion initiated with a Buy at BofA
10/06/21
Fly Intel: Top five analyst initiations
TRUP Trupanion
$124.37 /

-2.06 (-1.63%)

TRUP Trupanion
$124.37 /

-2.06 (-1.63%)

Conference/Events
Principal Financial management to meet virtually with Piper Sandler » 14:42
11/29/21
11/29
14:42
11/29/21
14:42
PFG

Principal Financial

$71.36 /

+0.39 (+0.55%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFG Principal Financial
$71.36 /

+0.39 (+0.55%)

PFG Principal Financial
$71.36 /

+0.39 (+0.55%)

10/28/21 RBC Capital
Principal Financial price target raised to $71 from $67 at RBC Capital
10/12/21 Barclays
Principal Financial price target raised to $76 from $69 at Barclays
07/08/21 Piper Sandler
Principal Financial price target lowered to $67 from $69 at Piper Sandler
07/06/21 Credit Suisse
Principal Financial upgraded to Outperform from Neutral at Credit Suisse
PFG Principal Financial
$71.36 /

+0.39 (+0.55%)

PFG Principal Financial
$71.36 /

+0.39 (+0.55%)

Hot Stocks
Novavax trading resumes  14:42
11/29/21
11/29
14:42
11/29/21
14:42
NVAX

Novavax

$212.62 /

-5.2 (-2.39%)

 
ShowHide Related Items >><<
NVAX Novavax
$212.62 /

-5.2 (-2.39%)

NVAX Novavax
$212.62 /

-5.2 (-2.39%)

09:06 Today B. Riley
Omicron reemphasizes importance of Novavax vaccine, says B. Riley
11/08/21 B. Riley
Novavax not a one-trick pony, says B. Riley
10/20/21 Cantor Fitzgerald
Novavax submissions will 'dissipate the current debate,' says Cantor Fitzgerald
09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
NVAX Novavax
$212.62 /

-5.2 (-2.39%)

NVAX Novavax
$212.62 /

-5.2 (-2.39%)

NVAX Novavax
$212.62 /

-5.2 (-2.39%)

NVAX Novavax
$212.62 /

-5.2 (-2.39%)

Hot Stocks
Novavax trading halted, volatility trading pause  14:37
11/29/21
11/29
14:37
11/29/21
14:37
NVAX

Novavax

$213.47 /

-4.35 (-2.00%)

 
ShowHide Related Items >><<
NVAX Novavax
$213.47 /

-4.35 (-2.00%)

NVAX Novavax
$213.47 /

-4.35 (-2.00%)

09:06 Today B. Riley
Omicron reemphasizes importance of Novavax vaccine, says B. Riley
11/08/21 B. Riley
Novavax not a one-trick pony, says B. Riley
10/20/21 Cantor Fitzgerald
Novavax submissions will 'dissipate the current debate,' says Cantor Fitzgerald
09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
NVAX Novavax
$213.47 /

-4.35 (-2.00%)

NVAX Novavax
$213.47 /

-4.35 (-2.00%)

NVAX Novavax
$213.47 /

-4.35 (-2.00%)

NVAX Novavax
$213.47 /

-4.35 (-2.00%)

General news
Black Friday sales reportedly saw strong foot traffic versus 2020 » 14:35
11/29/21
11/29
14:35
11/29/21
14:35
$ECON

Economic Data

/

+

Black Friday sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
AbbVie management to meet virtually with Mizuho » 14:28
11/29/21
11/29
14:28
11/29/21
14:28
ABBV

AbbVie

$117.52 /

+1.31 (+1.13%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$117.52 /

+1.31 (+1.13%)

ABBV AbbVie
$117.52 /

+1.31 (+1.13%)

11/24/21 Truist
AbbVie price target raised to $135 from $118 at Truist
11/23/21 Societe Generale
Societe Generale upgrades AbbVie to Buy on better than anticipated execution
11/23/21 Societe Generale
AbbVie upgraded to Buy from Hold at Societe Generale
11/18/21 Piper Sandler
Vertex downgraded to Neutral at Piper ahead of AbbVie CF data
ABBV AbbVie
$117.52 /

+1.31 (+1.13%)

ABBV AbbVie
$117.52 /

+1.31 (+1.13%)

ABBV AbbVie
$117.52 /

+1.31 (+1.13%)

ABBV AbbVie
$117.52 /

+1.31 (+1.13%)

Technical Analysis
NASDAQ market internals summary » 14:23
11/29/21
11/29
14:23
11/29/21
14:23
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 14:22
11/29/21
11/29
14:22
11/29/21
14:22
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Recommendations
Stifel expects neutral reaction for Blueprint acquisition of Lengo Therapeutics » 14:07
11/29/21
11/29
14:07
11/29/21
14:07
BPMC

Blueprint Medicines

$99.22 /

-1.63 (-1.62%)

Stifel analyst Bradley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$99.22 /

-1.63 (-1.62%)

BPMC Blueprint Medicines
$99.22 /

-1.63 (-1.62%)

12:12 Today Piper Sandler
Blueprint acquisition may surprise investors looking for buyout, says Piper
11/19/21 Morgan Stanley
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
10/28/21 Stifel
Stifel raises Blueprint Medicines target to $108 given faster Ayvakit launch
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
BPMC Blueprint Medicines
$99.22 /

-1.63 (-1.62%)

Periodicals
White House not reconsidering oil reserve release, Reuters reports » 14:05
11/29/21
11/29
14:05
11/29/21
14:05
BP

BP

$26.38 /

+0.63 (+2.45%)

, COP

ConocoPhillips

$73.01 /

+1.735 (+2.43%)

, TOT

TotalEnergies

/

+

, XOM

Exxon Mobil

$62.06 /

+1.16 (+1.90%)

, CVX

Chevron

$116.03 /

+1.98 (+1.74%)

, RDS.A

Royal Dutch Shell

$42.74 /

+0.99 (+2.37%)

White House press…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BP BP
$26.38 /

+0.63 (+2.45%)

COP ConocoPhillips
$73.01 /

+1.735 (+2.43%)

TOT TotalEnergies
/

+

XOM Exxon Mobil
$62.06 /

+1.16 (+1.90%)

CVX Chevron
$116.03 /

+1.98 (+1.74%)

RDS.A Royal Dutch Shell
$42.74 /

+0.99 (+2.37%)

BP BP
$26.38 /

+0.63 (+2.45%)

13:14 Today JPMorgan
BP price target raised to 570 GBp from 530 GBp at JPMorgan
11/09/21 Morgan Stanley
BP price target raised to 401 GBp from 388 GBp at Morgan Stanley
10/25/21 TD Securities
BP initiated with a Hold at TD Securities
10/15/21 Berenberg
BP upgraded to Buy from Hold at Berenberg
COP ConocoPhillips
$73.01 /

+1.735 (+2.43%)

11/10/21 Societe Generale
ConocoPhillips downgraded to Hold from Buy at Societe Generale
11/08/21 Argus
ConocoPhillips price target raised to $89 from $66 at Argus
10/26/21 Mizuho
ConocoPhillips price target raised to $99 from $88 at Mizuho
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
TOT TotalEnergies
/

+

09/30/21 Citi
Citi downgrades APA Corp. to Neutral on lack of near-term Suriname upside
07/22/21 HSBC
TotalEnergies price target lowered to EUR 41.90 from EUR 49 at HSBC
06/09/21
Fly Intel: Top five analyst initiations
06/09/21 MKM Partners
TotalEnergies initiated with a Buy at MKM Partners
XOM Exxon Mobil
$62.06 /

+1.16 (+1.90%)

11/02/21
Fly Intel: Top five analyst downgrades
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
11/02/21 Truist
Exxon Mobil downgraded to Sell from Hold at Truist
10/21/21 Morgan Stanley
Exxon Mobil, Chevron look poised for 'catch up trade,' says Morgan Stanley
CVX Chevron
$116.03 /

+1.98 (+1.74%)

11/24/21
Fly Intel: Top five analyst upgrades
11/24/21 RBC Capital
Chevron upgraded to Outperform from Sector Perform at RBC Capital
11/16/21 BofA
Chevron 'in the best shape of the past decade,' says BofA
11/15/21
Fly Intel: Top five analyst upgrades
RDS.A Royal Dutch Shell
$42.74 /

+0.99 (+2.37%)

11/17/21 Scotiabank
Royal Dutch Shell upgraded to Outperform at Scotiabank
11/17/21 Scotiabank
Shell Class B upgraded to Outperform from Sector Perform at Scotiabank
11/15/21 UBS
Royal Dutch Shell price target raised to 2,125 GBp from 1,860 GBp at UBS
11/09/21 Morgan Stanley
Royal Dutch Shell price target raised to 2,136 GBp at Morgan Stanley
BP BP
$26.38 /

+0.63 (+2.45%)

COP ConocoPhillips
$73.01 /

+1.735 (+2.43%)

XOM Exxon Mobil
$62.06 /

+1.16 (+1.90%)

CVX Chevron
$116.03 /

+1.98 (+1.74%)

RDS.A Royal Dutch Shell
$42.74 /

+0.99 (+2.37%)

BP BP
$26.38 /

+0.63 (+2.45%)

COP ConocoPhillips
$73.01 /

+1.735 (+2.43%)

TOT TotalEnergies
/

+

XOM Exxon Mobil
$62.06 /

+1.16 (+1.90%)

CVX Chevron
$116.03 /

+1.98 (+1.74%)

RDS.A Royal Dutch Shell
$42.74 /

+0.99 (+2.37%)

BP BP
$26.38 /

+0.63 (+2.45%)

COP ConocoPhillips
$73.01 /

+1.735 (+2.43%)

TOT TotalEnergies
/

+

XOM Exxon Mobil
$62.06 /

+1.16 (+1.90%)

CVX Chevron
$116.03 /

+1.98 (+1.74%)

RDS.A Royal Dutch Shell
$42.74 /

+0.99 (+2.37%)

BP BP
$26.38 /

+0.63 (+2.45%)

COP ConocoPhillips
$73.01 /

+1.735 (+2.43%)

TOT TotalEnergies
/

+

XOM Exxon Mobil
$62.06 /

+1.16 (+1.90%)

CVX Chevron
$116.03 /

+1.98 (+1.74%)

Options
Crispr Therapeutics call volume above normal and directionally bullish » 14:05
11/29/21
11/29
14:05
11/29/21
14:05
CRSP

Crispr Therapeutics

$79.10 /

+0.34 (+0.43%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$79.10 /

+0.34 (+0.43%)

CRSP Crispr Therapeutics
$79.10 /

+0.34 (+0.43%)

11/16/21 Truist
Truist keeps Buy on Crispr Therapeutics after diabetes dosing approved
11/08/21 Goldman Sachs
Bluebird Bio downgraded to Sell from Neutral at Goldman Sachs
11/04/21 Raymond James
ASH abstracts justify Crispr Therapeutics concerns, says Raymond James
11/04/21 Oppenheimer
Crispr Therapeutics price target lowered to $172 from $185 at Oppenheimer
CRSP Crispr Therapeutics
$79.10 /

+0.34 (+0.43%)

CRSP Crispr Therapeutics
$79.10 /

+0.34 (+0.43%)

CRSP Crispr Therapeutics
$79.10 /

+0.34 (+0.43%)

Recommendations
Remy Cointreau price target raised to EUR 208 from EUR 158 at Berenberg » 13:54
11/29/21
11/29
13:54
11/29/21
13:54
REMYY

Remy Cointreau

$24.14 /

+2.885 (+13.58%)

Berenberg analyst Javier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$24.14 /

+2.885 (+13.58%)

13:21 Today Societe Generale
Remy Cointreau price target raised to EUR 185 from EUR 160 at Societe Generale
11/26/21 Deutsche Bank
Remy Cointreau price target raised to EUR 250 from EUR 216 at Deutsche Bank
11/26/21 Barclays
Remy Cointreau price target raised to EUR 262 from EUR 234 at Barclays
11/15/21 Barclays
Remy Cointreau upgraded to Overweight from Equal Weight at Barclays
Recommendations
Forterra plc price target lowered to 280 GBp from 300 GBp at Berenberg » 13:53
11/29/21
11/29
13:53
11/29/21
13:53
FTTRF

Forterra plc

$4.34 /

+ (+0.00%)

Berenberg analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTTRF Forterra plc
$4.34 /

+ (+0.00%)

06:25 Today Citi
Forterra plc upgraded to Buy from Neutral at Citi
03/10/21 Deutsche Bank
Forterra plc price target raised to 296 GBp from 284 GBp at Deutsche Bank
Recommendations
Peloton price target lowered to $56 from $70 at Stifel » 13:51
11/29/21
11/29
13:51
11/29/21
13:51
PTON

Peloton

$43.91 /

-2.42 (-5.22%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTON Peloton
$43.91 /

-2.42 (-5.22%)

PTON Peloton
$43.91 /

-2.42 (-5.22%)

11/16/21 Baird
Baird adds Peloton as 'Fresh Pick,' says capital raise removes overhang
11/16/21 BMO Capital
Peloton 'backpedaling again' with $1B offering, says BMO Capital
11/11/21 RBC Capital
Affirm price target raised to $175 from $130 at RBC Capital
11/09/21 JMP Securities
Peloton should be bought on weakness, says JMP Securities
PTON Peloton
$43.91 /

-2.42 (-5.22%)

  • 16
    Nov
PTON Peloton
$43.91 /

-2.42 (-5.22%)

PTON Peloton
$43.91 /

-2.42 (-5.22%)

PTON Peloton
$43.91 /

-2.42 (-5.22%)

General news
Wall Street added to early gains, » 13:50
11/29/21
11/29
13:50
11/29/21
13:50
$ECON

Economic Data

/

+

Wall Street added to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
S4 Capital price target lowered to 1.050 GBp from 1,200 GBp at Morgan Stanley » 13:49
11/29/21
11/29
13:49
11/29/21
13:49
SCPPF

S4 Capital

$8.89 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCPPF S4 Capital
$8.89 /

+ (+0.00%)

11/11/21 Credit Suisse
S4 Capital price target lowered to 830 GBp from 877 GBp at Credit Suisse
10/11/21 HSBC
S4 Capital downgraded to Hold from Buy at HSBC
10/08/21 Barclays
S4 Capital price target raised to 800 GBp from 775 GBp at Barclays
09/14/21 Barclays
S4 Capital price target raised to 775 GBp from 540 GBp at Barclays
Recommendations
Schroders price target lowered to 3,920 GBp from 3,930 GBp at Morgan Stanley » 13:48
11/29/21
11/29
13:48
11/29/21
13:48
SHNWF

Schroders

$47.70 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHNWF Schroders
$47.70 /

+ (+0.00%)

10/27/21 Morgan Stanley
Schroders price target raised to 3,930 GBp from 3,700 GBp at Morgan Stanley
10/07/21 Morgan Stanley
Schroders price target lowered to 3,700 GBp from 3,890 GBp at Morgan Stanley
08/04/21 RBC Capital
Schroders price target raised to 3,600 GBp from 3,400 GBp at RBC Capital
08/03/21 UBS
Schroders price target raised to 4,250 GBp from 4,175 GBp at UBS
Recommendations
Euronext price target lowered to EUR 101 from EUR 104.30 at Morgan Stanley » 13:48
11/29/21
11/29
13:48
11/29/21
13:48
EUXTF

Euronext

$101.00 /

+0.4 (+0.40%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EUXTF Euronext
$101.00 /

+0.4 (+0.40%)

10/19/21 Deutsche Bank
Euronext price target raised to EUR 116 from EUR 112 at Deutsche Bank
10/14/21 Morgan Stanley
Euronext price target raised to EUR 104.30 from EUR 103.10 at Morgan Stanley
08/27/21 HSBC
Euronext downgraded to Hold from Buy at HSBC
08/27/21 HSBC
Euronext downgraded to Hold from Buy at HSBC
Hot Stocks
Kraft Heinz completes sale of natural cheese business for $3.3B » 13:47
11/29/21
11/29
13:47
11/29/21
13:47
KHC

Kraft Heinz

$34.64 /

-0.19 (-0.55%)

The Kraft Heinz Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KHC Kraft Heinz
$34.64 /

-0.19 (-0.55%)

KHC Kraft Heinz
$34.64 /

-0.19 (-0.55%)

09/21/21 Morgan Stanley
Kraft Heinz assumed with an Equal Weight at Morgan Stanley
09/08/21 Stifel
Kraft Heinz outlines 'confident' view of business, says Stifel
08/20/21 Piper Sandler
Kraft Heinz price target lowered to $39 from $41 at Piper Sandler
05/05/21
Fly Intel: Top five analyst downgrades
KHC Kraft Heinz
$34.64 /

-0.19 (-0.55%)

  • 18
    Nov
KHC Kraft Heinz
$34.64 /

-0.19 (-0.55%)

KHC Kraft Heinz
$34.64 /

-0.19 (-0.55%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.